Helicobacter Pylori Infections Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting helicobacter pylori infections clinical trials across 6 countries. Studies span Phase 4, Not Applicable, Phase 2, Phase 3. Top locations include Jinan, Shandong, China, Nanjing, Jiangsu, China, Poitiers, France. Updated daily from ClinicalTrials.gov.


Helicobacter Pylori Infections Trials at a Glance

9 actively recruiting trials for helicobacter pylori infections are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 4 with 3 trials, with the heaviest enrollment activity in Jinan, Nanjing, and Poitiers. Lead sponsors running helicobacter pylori infections studies include Nanjing First Hospital, Nanjing Medical University, National Taiwan University Hospital, and International Agency for Research on Cancer.

Browse helicobacter pylori infections trials by phase

Treatments under study

About Helicobacter Pylori Infections Clinical Trials

Looking for clinical trials for Helicobacter Pylori Infections? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Helicobacter Pylori Infections trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Helicobacter Pylori Infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori Infections
National Taiwan University Hospital990 enrolled1 locationNCT07576959
Recruiting
Not Applicable

Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial

Helicobacter Pylori Infections
Yanqing Li372 enrolled2 locationsNCT07179159
Recruiting
Phase 4

Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.

Metabolic SyndromeHelicobacter Pylori Infections
Nanjing First Hospital, Nanjing Medical University120 enrolled1 locationNCT07306988
Recruiting

Registry for the Management of Helicobacter Pylori Infection in Shandong Province

Helicobacter Pylori Infections
Yueyue Li10,000 enrolled2 locationsNCT07335406
Recruiting

Endoscopic Screening of Asymptomatic Patients for Helicobacter Pylori, Intestinal Metaplasia, and Barrett's Mucosa During Screening Colonoscopy

Helicobacter Pylori InfectionsIntestinal MetaplasiaBarett's Esophagus
Sigmund Freud PrivatUniversitat1,000 enrolled1 locationNCT07346521
Recruiting
Phase 2

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Helicobacter Pylori InfectionsHelicobacter InfectionHelicobacter Pylori Gastrointestinal Tract Infection+1 more
Tanta University66 enrolled1 locationNCT07293910
Recruiting

Feasibility Study to Diagnose Helicobacter Pylori in the Paediatric Population Using Non-invasive Fecal Analysis

Helicobacter Pylori Infections
Poitiers University Hospital188 enrolled1 locationNCT07083804
Recruiting
Phase 4

Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality

Gastric CancerHelicobacter Pylori InfectionsAtrophic Gastritis
International Agency for Research on Cancer30,000 enrolled1 locationNCT02047994
Recruiting
Phase 4

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Helicobacter Pylori Infections
Shandong University330 enrolled1 locationNCT06723197